Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

BUY
$0.33 - $0.7 $21 - $46
66 Added 8.78%
818 $0
Q2 2022

Aug 10, 2022

SELL
$0.98 - $1.68 $7,938 - $13,608
-8,100 Reduced 91.5%
752 $1,000
Q1 2022

May 04, 2022

BUY
$1.19 - $1.71 $1,608 - $2,311
1,352 Added 18.03%
8,852 $12,000
Q3 2021

Nov 05, 2021

BUY
$2.78 - $3.63 $18,992 - $24,800
6,832 Added 1022.75%
7,500 $21,000
Q2 2021

Aug 02, 2021

SELL
$1.8 - $5.25 $9,720 - $28,350
-5,400 Reduced 88.99%
668 $2,000
Q1 2021

May 13, 2021

BUY
$2.1 - $3.89 $2,100 - $3,890
1,000 Added 19.73%
6,068 $14,000
Q4 2020

Feb 10, 2021

BUY
$1.94 - $2.64 $9,700 - $13,200
5,000 Added 7352.94%
5,068 $10,000
Q1 2020

May 18, 2020

BUY
$0.68 - $2.3 $46 - $156
68 New
68 $0

Others Institutions Holding PRPO

# of Institutions
1
Shares Held
340
Call Options Held
0
Put Options Held
0

About Precipio, Inc.


  • Ticker PRPO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 22,736,500
  • Market Cap $143M
  • Description
  • Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust geneti...
More about PRPO
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.